Observations in venous thromboembolism.
Stein
P D
PD
D003362:Cost-Benefit Analysis; D004797:Enzyme-Linked Immunosorbent Assay / Q000191:economics; D005165:Factor V / Q000378:metabolism*; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D006801:Humans; D011237:Predictive Value of Tests; D011446:Prospective Studies; D011516:Prothrombin / Q000378:metabolism*; D011655:Pulmonary Embolism / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000209:etiology; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000191:economics / Q000295:instrumentation; D014463:Ultrasonography / Q000191:economics / Q000379:methods; D014481:United States; D020246:Venous Thrombosis / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging
D005338:Fibrin Fibrinogen Degradation Products; C095381:factor V Leiden; C036309:fibrin fragment D; D005165:Factor V; D011516:Prothrombin; C025337:Factor IIa